These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23267792)

  • 21. Effects of heme oxygenase-1 transgenic islets on transplantation.
    Tu CF; Kuo CH; Juang JH
    Transplant Proc; 2005 Oct; 37(8):3463-7. PubMed ID: 16298630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene transfer of manganese superoxide dismutase extends islet graft function in a mouse model of autoimmune diabetes.
    Bertera S; Crawford ML; Alexander AM; Papworth GD; Watkins SC; Robbins PD; Trucco M
    Diabetes; 2003 Feb; 52(2):387-93. PubMed ID: 12540612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Introduction of Human Heme Oxygenase-1 and Soluble Tumor Necrosis Factor-α Receptor Type I With Human IgG1 Fc in Porcine Islets Prolongs Islet Xenograft Survival in Humanized Mice.
    Lee HS; Lee JG; Yeom HJ; Chung YS; Kang B; Hurh S; Cho B; Park H; Hwang JI; Park JB; Ahn C; Kim SJ; Yang J
    Am J Transplant; 2016 Jan; 16(1):44-57. PubMed ID: 26430779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decoy receptor 3 protects non-obese diabetic mice from autoimmune diabetes by regulating dendritic cell maturation and function.
    Wang YL; Chou FC; Sung HH; Fan PL; Hsueh CW; Lin WC; Chen SJ; Lin WW; Sytwu HK
    Mol Immunol; 2010 Oct; 47(16):2552-62. PubMed ID: 20801512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
    J Immunol; 1997 Dec; 159(12):6298-303. PubMed ID: 9550435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice.
    Casares S; Lin M; Zhang N; Teijaro JR; Stoica C; McEvoy R; Farber DL; Bona C; Brumeanu TD
    Transplantation; 2008 Jun; 85(12):1717-25. PubMed ID: 18580462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
    Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts.
    Gysemans CA; Waer M; Valckx D; Laureys JM; Mihkalsky D; Bouillon R; Mathieu C
    Diabetes; 2000 Dec; 49(12):1992-7. PubMed ID: 11117999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice.
    Luo X; Yang H; Kim IS; Saint-Hilaire F; Thomas DA; De BP; Ozkaynak E; Muthukumar T; Hancock WW; Crystal RG; Suthanthiran M
    Transplantation; 2005 May; 79(9):1091-6. PubMed ID: 15880049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents.
    Gysemans C; Stoffels K; Giulietti A; Overbergh L; Waer M; Lannoo M; Feige U; Mathieu C
    Diabetologia; 2003 Aug; 46(8):1115-23. PubMed ID: 12879250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice.
    Zhang YC; Pileggi A; Agarwal A; Molano RD; Powers M; Brusko T; Wasserfall C; Goudy K; Zahr E; Poggioli R; Scott-Jorgensen M; Campbell-Thompson M; Crawford JM; Nick H; Flotte T; Ellis TM; Ricordi C; Inverardi L; Atkinson MA
    Diabetes; 2003 Mar; 52(3):708-16. PubMed ID: 12606512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triptolide ameliorates autoimmune diabetes and prolongs islet graft survival in nonobese diabetic mice.
    Huang SH; Lin GJ; Chu CH; Yu JC; Chen TW; Chen YW; Chien MW; Chu CC; Sytwu HK
    Pancreas; 2013 Apr; 42(3):442-51. PubMed ID: 23146919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice.
    Abdulreda MH; Molano RD; Faleo G; Lopez-Cabezas M; Shishido A; Ulissi U; Fotino C; Hernandez LF; Tschiggfrie A; Aldrich VR; Tamayo-Garcia A; Bayer AS; Ricordi C; Caicedo A; Buchwald P; Pileggi A; Berggren PO
    Diabetologia; 2019 Jul; 62(7):1237-1250. PubMed ID: 31087105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of recurrent but not spontaneous autoimmune diabetes by transplanted NOD islets adenovirally transduced with immunomodulating molecules.
    Sakata M; Yasuda H; Moriyama H; Yamada K; Kotani R; Kurohara M; Okumachi Y; Kishi M; Arai T; Hara K; Hamada H; Yokono K; Nagata M
    Diabetes Res Clin Pract; 2008 Jun; 80(3):352-9. PubMed ID: 18400329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation.
    Yang Z; Chen M; Ellett JD; Fialkow LB; Carter JD; Nadler JL
    Transplantation; 2004 Jan; 77(1):55-60. PubMed ID: 14724435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testicular Sertoli cells exert both protective and destructive effects on syngeneic islet grafts in non-obese diabetic mice.
    Korbutt GS; Suarez-Pinzon WL; Power RF; Rajotte RV; Rabinovitch A
    Diabetologia; 2000 Apr; 43(4):474-80. PubMed ID: 10819241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Islet mass plays a critical role in initiation, but not progression, of the diabetogenic process in NOD mice.
    Kimura T; Ito A; Hancock WW; Maki T
    J Autoimmun; 1999 Jun; 12(4):243-9. PubMed ID: 10330295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune destruction of islet grafts in the NOD mouse is resistant to 15-deoxyspergualin but sensitive to anti-CD4 antibody.
    Stegall MD; Loberman Z; Ostrowska A; Coulombe M; Gill RG
    J Surg Res; 1996 Aug; 64(2):156-60. PubMed ID: 8812627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
    Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
    Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival of an islet allograft deficient in iNOS after implantation into diabetic NOD mice.
    Börjesson A; Andersson AK; Sandler S
    Cell Transplant; 2006; 15(8-9):769-75. PubMed ID: 17269447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.